{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:24:12Z","timestamp":1794097452952,"version":"4.8.0"},"reference-count":56,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Artif Organs"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:p>Continuous renal replacement therapy (CRRT) is traditionally used for solute and fluid removal in critically ill patients with acute kidney injury. Emerging evidence suggests that CRRT may also influence systemic biological networks, including inflammation, vascular function, immunity, and metabolism. In sepsis and critical illness, these systems are dynamically dysregulated, involving fluctuating inflammatory mediators, endothelial alterations, immune dysfunction ranging from hyperinflammation to immunoparalysis, and metabolic reprogramming that varies with disease stage. We propose a conceptual framework in which CRRT modulates these interconnected processes. Beyond solute and cytokine removal, CRRT may affect the distribution of circulating mediators, attenuate concentration peaks, influence endothelial stability, and modulate immune and metabolic states, thereby contributing to systemic network regulation. However, CRRT has bidirectional effects. While it may help restore homeostasis by removing harmful mediators, it may also eliminate beneficial molecules and induce inflammatory or oxidative responses due to extracorporeal circulation. Therefore, its overall impact is likely context-dependent and influenced by treatment settings and patient condition. Although direct evidence for systemic reprogramming remains limited, this framework provides a basis for future research. Integrative biomarker-based and phenotyping approaches may support the development of individualized and adaptive CRRT strategies in critical care.<\/jats:p>","DOI":"10.1177\/03913988261473824","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:39:13Z","timestamp":1787891953000},"page":"839-848","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Toward a conceptual framework for systemic effects of continuous renal replacement therapy in critical illness"],"prefix":"10.1177","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4354-7690","authenticated-orcid":false,"given":"Yusuke","family":"Nishimura","sequence":"first","affiliation":[{"name":"Department of Medical Technology and Clinical Engineering, Faculty of Medical Technology and Clinical Engineering, Gunma University of Health and Welfare, Maebashi City, Gunma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Neyra JA Yessayan L Thompson Bastin ML et al. How to prescribe and troubleshoot continuous renal replacement therapy: a case-based review. Kidney360 2020; 2(2): 371\u2013384. https:\/\/doi.org\/10.34067\/KID.0004912020","DOI":"10.34067\/KID.0004912020"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Vella R Panci D Carini F et al. Cytokines in sepsis: a critical review of the literature on systemic inflammation and multiple organ dysfunction. Front Immunol 2025; 16: 1682306. https:\/\/doi.org\/10.3389\/fimmu.2025.1682306","DOI":"10.3389\/fimmu.2025.1682306"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Cicchinelli S Pignataro G Gemma S et al. PAMPs and DAMPs in sepsis: a review of their molecular features and potential clinical implications. Int J Mol Sci 2024; 25(2): 962. https:\/\/doi.org\/10.3390\/ijms25020962","DOI":"10.3390\/ijms25020962"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Borges A Bento L. Organ crosstalk and dysfunction in sepsis. Ann Intensive Care 2024; 14(1): 147. https:\/\/doi.org\/10.1186\/s13613-024-01377-0","DOI":"10.1186\/s13613-024-01377-0"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Wu S Xu T Wu C et al. Continuous renal replacement therapy in sepsis-associated acute kidney injury: effects on inflammatory mediators and coagulation function. Asian J Surg 2021; 44(10): 1254\u20131259. https:\/\/doi.org\/10.1016\/j.asjsur.2021.02.004","DOI":"10.1016\/j.asjsur.2021.02.004"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Nakamura Y Hatomoto H Yamasaki S et al. Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial. Eur J Med Res 2023; 28(1): 208. https:\/\/doi.org\/10.1186\/s40001-023-01184-6","DOI":"10.1186\/s40001-023-01184-6"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Theisen BE Lichtenstern C Nusshag C et al. Simultaneous removal of endotoxins inflammatory mediators and uremic toxins in ICU patients with septic shock: a retrospective cohort study. Sci Rep 2024; 14(1): 19645. https:\/\/doi.org\/10.1038\/s41598-024-70522-3","DOI":"10.1038\/s41598-024-70522-3"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Erd\u00e9lyi L Tr\u00e1sy D. CRRT is more than just continuous renal replacement therapy. Pharmaceuticals (Basel) 2024; 17(12): 1571. https:\/\/doi.org\/10.3390\/ph17121571","DOI":"10.3390\/ph17121571"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","unstructured":"Stevens NE Chapman MJ Fraser CK et al. Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes. Sci Rep 2017; 7(1): 5850. https:\/\/doi.org\/10.1038\/s41598-017-06205-z","DOI":"10.1038\/s41598-017-06205-z"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Li Y Sun P Chang K et al. Effect of continuous renal replacement therapy with the oXiris Hemofilter on critically Ill patients: a narrative review. J Clin Med 2022; 11(22): 6719. https:\/\/doi.org\/10.3390\/jcm11226719","DOI":"10.3390\/jcm11226719"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"Lumlertgul N Hall A Camporota L et al. Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study). Crit Care 2021; 5(1): 39. https:\/\/doi.org\/10.1186\/s13054-021-03476-x","DOI":"10.1186\/s13054-021-03476-x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Xiang H Song B Zhang Y et al. The effectiveness of continuous renal replacement therapy in critical COVID-19 patients with cytokine release syndrome: a retrospective multicenter descriptive study from Wuhan China. Aging (Albany NY) 2021; 13(7): 9243\u20139252. https:\/\/doi.org\/10.18632\/aging.202838","DOI":"10.18632\/aging.202838"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"Liu S Liang Q. Sepsis toxicity network reconstruction-Dynamic signaling and multi-organ injury: a review. Biomol Biomed 2025; 26(2): 262\u2013273. https:\/\/doi.org\/10.17305\/bb.2025.12931","DOI":"10.17305\/bb.2025.12931"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Candelli M Sacco Fernandez M Rozzi G et al. The interleukin network in sepsis: from cytokine storm to clinical applications. Diagnostics (Basel) 2025; 15(22): 2927. https:\/\/doi.org\/10.3390\/diagnostics15222927","DOI":"10.3390\/diagnostics15222927"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Dubinsky SDJ Watt KM Imburgia CE et al. Anakinra removal by continuous renal replacement therapy: an ex vivo analysis. Crit Care Explor 2023; 5(12): e1010. https:\/\/doi.org\/10.1097\/CCE.0000000000001010","DOI":"10.1097\/CCE.0000000000001010"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"Chen LX Demirjian S Udani SM et al. Cytokine clearances in critically Ill patients on continuous renal replacement therapy. Blood Purif 2018; 46(4): 315\u2013322. https:\/\/doi.org\/10.1159\/000492025","DOI":"10.1159\/000492025"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","unstructured":"Zhang W Jiang L Tong X et al. Sepsis-induced endothelial dysfunction: permeability and regulated cell death. J Inflamm Res 2024; 17: 9953\u20139973. https:\/\/doi.org\/10.2147\/JIR.S479926","DOI":"10.2147\/JIR.S479926"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Pan Y Ma Y Wan K et al. Endothelial cell injury: a crucial link in microcirculatory dysfunction associated with sepsis. World J Emerg Med 2026; 17(1): 28\u201335. https:\/\/doi.org\/10.5847\/wjem.j.1920-8642.2025.093","DOI":"10.5847\/wjem.j.1920-8642.2025.093"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"He H Zhang W Jiang L et al. Endothelial cell dysfunction due to molecules secreted by macrophages in sepsis. Biomolecules 2024; 14(8): 980. https:\/\/doi.org\/10.3390\/biom14080980","DOI":"10.3390\/biom14080980"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","unstructured":"Miao H Wang C Cui Y et al. Continuous renal replacement therapy attenuates endothelial injury biomarkers in pediatric sepsis: a prospective cohort study. Ren Fail 2026; 48(1): 2639791. https:\/\/doi.org\/10.1080\/0886022X.2026.2639791","DOI":"10.1080\/0886022X.2026.2639791"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Hou PC Filbin MR Wang H et al. Endothelial permeability and hemostasis in septic shock: results From the ProCESS trial. Chest 2017; 152(1): 22\u201331. https:\/\/doi.org\/10.1016\/j.chest.2017.01.010","DOI":"10.1016\/j.chest.2017.01.010"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"Xu J. A review: continuous renal replacement therapy for sepsis-associated acute kidney injury. All Life 2023; 16(1): 2163305. https:\/\/doi.org\/10.1080\/26895293.2022.2163305","DOI":"10.1080\/26895293.2022.2163305"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","unstructured":"Zarbock A Ger\u00df J Van Aken H et al. Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (The ELAIN-Trial): study protocol for a randomized controlled trial. Trials 2016; 17(1): 148. https:\/\/doi.org\/10.1186\/s13063-016-1249-9","DOI":"10.1186\/s13063-016-1249-9"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Tamme K Maddison L Kruusat R et al. Effects of high volume haemodiafiltration on inflammatory response profile and microcirculation in patients with septic shock. Biomed Res Int 2015; 2015: 125615. https:\/\/doi.org\/10.1155\/2015\/125615","DOI":"10.1155\/2015\/125615"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","unstructured":"Hotchkiss RS Monneret G Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013; 13(12): 862\u2013874. https:\/\/doi.org\/10.1038\/nri3552","DOI":"10.1038\/nri3552"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Jensen IJ Sjaastad FV Griffith TS et al. Sepsis-induced T cell immunoparalysis: the Ins and outs of impaired T cell immunity. J Immunol 2018; 200(5): 1543\u20131553. https:\/\/doi.org\/10.4049\/jimmunol.1701618","DOI":"10.4049\/jimmunol.1701618"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Yang Y Zhang Y Wu J et al. Decoding immune low-response states in sepsis: single-cell and 3D spatial transcriptomic insights into immunoparalysis. Front Immunol 2025; 16: 1696914. https:\/\/doi.org\/10.3389\/fimmu.2025.1696914","DOI":"10.3389\/fimmu.2025.1696914"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","unstructured":"Nakamori Y Park EJ Shimaoka M. Immune deregulation in sepsis and septic shock: reversing immune paralysis by targeting PD-1\/PD-L1 pathway. Front Immunol 2021; 11: 624279. https:\/\/doi.org\/10.3389\/fimmu.2020.624279","DOI":"10.3389\/fimmu.2020.624279"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","unstructured":"Gosselin D Link VM Romanoski CE et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 2014; 159(6): 1327\u20131340. https:\/\/doi.org\/10.1016\/j.cell.2014.11.023","DOI":"10.1016\/j.cell.2014.11.023"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","unstructured":"Pillay J Kamp VM van Hoffen E et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012; 122(1): 327\u2013336. https:\/\/doi.org\/10.1172\/JCI57990","DOI":"10.1172\/JCI57990"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","unstructured":"Mosser DM Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8(12): 958\u2013969. https:\/\/doi.org\/10.1038\/nri2448","DOI":"10.1038\/nri2448"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","unstructured":"Wright HL Moots RJ Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol 2014; 10(10): 593\u2013601. https:\/\/doi.org\/10.1038\/nrrheum.2014.80","DOI":"10.1038\/nrrheum.2014.80"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","unstructured":"Foster SL Hargreaves DC Medzhitov R. Gene\u2011specific control of inflammation by TLR\u2011induced chromatin modifications. Nature 2007; 447(7147): 972\u2013978. https:\/\/doi.org\/10.1038\/nature05836","DOI":"10.1038\/nature05836"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","unstructured":"Reyes M Filbin MR Bhattacharyya RP et al. An immune-cell signature of bacterial sepsis. Nat Med 2020; 26(3): 333\u2013340. https:\/\/doi.org\/10.1038\/s41591-020-0752-4","DOI":"10.1038\/s41591-020-0752-4"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.7.2068.2068"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","unstructured":"Silva MT. When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J Leukoc Biol 2010; 87(1): 93\u2013106. https:\/\/doi.org\/10.1189\/jlb.0809549","DOI":"10.1189\/jlb.0809549"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","unstructured":"O'Neill LA Kishton RJ Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol 2016; 16(9): 553\u2013565. https:\/\/doi.org\/10.1038\/nri.2016.70","DOI":"10.1038\/nri.2016.70"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","unstructured":"Kelly B O\u2019Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res 2015; 25(7): 771\u2013784. https:\/\/doi.org\/10.1038\/cr.2015.68","DOI":"10.1038\/cr.2015.68"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","unstructured":"Pearce EL Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity 2013; 38(4): 633\u2013643. https:\/\/doi.org\/10.1016\/j.immuni.2013.04.005","DOI":"10.1016\/j.immuni.2013.04.005"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","unstructured":"Caslin HL Abebayehu D Pinette JA et al. Lactate is a metabolic mediator that shapes immune cell fate and function. Front Physiol 2021; 12: 688485. https:\/\/doi.org\/10.3389\/fphys.2021.688485","DOI":"10.3389\/fphys.2021.688485"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","unstructured":"Zhang J Wu D Zeng F et al. Lactate metabolic reprogramming and histone lactylation modification in sepsis. Int J Biol Sci 2025; 21(11): 5034\u20135055. https:\/\/doi.org\/10.7150\/ijbs.116088","DOI":"10.7150\/ijbs.116088"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","unstructured":"Choi EJ Jang YY Choi EJ et al. The role of lactate in immune regulation: a metabolic rheostat via transporters receptors and epigenetic modifiers. Cells 2025; 14(14): 1096. https:\/\/doi.org\/10.3390\/cells14141096","DOI":"10.3390\/cells14141096"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","unstructured":"Yang K Fan M Wang X et al. Lactate induces vascular permeability via disruption of VE-cadherin in endothelial cells during sepsis. Sci Adv 2022; 8(17): eabm8965. https:\/\/doi.org\/10.1126\/sciadv.abm8965","DOI":"10.1126\/sciadv.abm8965"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","unstructured":"Certo M Tsai CH Pucino V et al. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol 2021; 21(3): 151\u2013161. https:\/\/doi.org\/10.1038\/s41577-020-0406-2","DOI":"10.1038\/s41577-020-0406-2"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","unstructured":"Schneider AG Picard W Honor\u00e9 PM et al. Amino acids and vitamins status during continuous renal replacement therapy: an ancillary prospective observational study of a randomised control trial. Anaesth Crit Care Pain Med 2021; 40(2): 100813. https:\/\/doi.org\/10.1016\/j.accpm.2021.100813","DOI":"10.1016\/j.accpm.2021.100813"},{"issue":"72","key":"e_1_3_2_47_2","article-title":"Metabolic aspects of continuous renal replacement therapies","author":"Druml W.","year":"1999","unstructured":"Druml W. Metabolic aspects of continuous renal replacement therapies. Kidney Int Suppl 1999; (72): S56\u2013S61.","journal-title":"Kidney Int Suppl"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","unstructured":"Gawaz M Bogner C. Changes in platelet membrane glycoproteins and platelet-leukocyte interaction during hemodialysis. Clin Investig 1994; 72(6): 424\u2013429. https:\/\/doi.org\/10.1007\/BF00180515","DOI":"10.1007\/BF00180515"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","unstructured":"Bowry SK Kircelli F Himmele R et al. Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation. Clin Kidney J 2021; 14(Suppl 4): i59\u2013i71. https:\/\/doi.org\/10.1093\/ckj\/sfab185","DOI":"10.1093\/ckj\/sfab185"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","unstructured":"\u00c1vila E Sep\u00falveda RA Retamal J et al. Biocompatibility in hemodialysis: artificial membrane and human blood interactions. BMC Nephrol 2025; 26(1): 482. https:\/\/doi.org\/10.1186\/s12882-025-04401-y","DOI":"10.1186\/s12882-025-04401-y"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","unstructured":"Ekdahl KN Fromell K Mannes M et al. Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop. Immunol Rev 2022; 313(1): 91\u2013103. https:\/\/doi.org\/10.1111\/imr.13148","DOI":"10.1111\/imr.13148"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","unstructured":"McDonald CI Fraser JF Coombes JS et al. Oxidative stress during extracorporeal circulation. Eur J Cardiothorac Surg 2014; 46(6): 937\u2013943. https:\/\/doi.org\/10.1093\/ejcts\/ezt637","DOI":"10.1093\/ejcts\/ezt637"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","unstructured":"Fishman G Singer P. Metabolic and nutritional aspects in continuous renal replacement therapy. J Intensive Med 2023; 3(3): 228\u2013238. https:\/\/doi.org\/10.1016\/j.jointm.2022.11.001","DOI":"10.1016\/j.jointm.2022.11.001"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","unstructured":"Ronco C Ricci Z De Backer D et al. Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care 2015; 19(1): 146. https:\/\/doi.org\/10.1186\/s13054-015-0850-8","DOI":"10.1186\/s13054-015-0850-8"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","unstructured":"Goldstein SL. Continuous renal replacement therapy: mechanism of clearance fluid removal indications and outcomes. Curr Opin Pediatr 2011; 23(2): 181\u2013185. https:\/\/doi.org\/10.1097\/MOP.0b013e328342fe67","DOI":"10.1097\/MOP.0b013e328342fe67"},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","unstructured":"Wang J Wu Z Wen Q et al. Effects of CRRT on renal function and toxin clearance in patients with sepsis: a case-control study. J Int Med Res 2021; 49(9): 3000605211042981. https:\/\/doi.org\/10.1177\/03000605211042981","DOI":"10.1177\/03000605211042981"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","unstructured":"Zou F Tang X Lei X et al. Treatment efficacy of continuous renal replacement on symptoms inflammatory mediators and coagulation function in patients with sepsis-associated acute kidney injury. Arch Esp Urol 2022; 75(9): 746\u2013752. https:\/\/doi.org\/10.56434\/j.arch.esp.urol.20227509.109","DOI":"10.56434\/j.arch.esp.urol.20227509.109"}],"container-title":["The International Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03913988261473824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03913988261473824","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03913988261473824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:49:16Z","timestamp":1794095356000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03913988261473824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10.1177\/03913988261473824"],"URL":"https:\/\/doi.org\/10.1177\/03913988261473824","relation":{},"ISSN":["0391-3988","1724-6040"],"issn-type":[{"value":"0391-3988","type":"print"},{"value":"1724-6040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}